Quotient Limited (NASDAQ:QTNT) will be hosting a conference call at 8:00 AM eastern time on 2nd November 2020, to discuss its 2Q21 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website quotientbd.com
Earnings Expectation
Quotient Limited is expected to report second quarter earnings results, before market open, on Monday 2nd November 2020. Analysts polled by Thomson Reuters anticipate second quarter loss of $ 0.33 per share from revenue of $ 7.90 million. Looking ahead, the full year loss are expected at $ 1.34 per share on the revenues of $ 34.86 million.
The Company Outlook
Full Year 2021 topline are forecasted in a range of$ 32.00 million ~ $ 34.00 million
Click Here For More Historical Outlooks Of Quotient Limited
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood-group antigens; reagent red blood cells, which enable the identification of blood-group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping.
